136310-93-5

  • Product Name:Tiotropium Bromide
  • Molecular Formula:C19H22BrNO4S2
  • Purity:99%
  • Molecular Weight:472.42
InquiryAdd to cart

Product Details;

CasNo: 136310-93-5

Molecular Formula: C19H22BrNO4S2

Appearance: White solid

Buy Reliable Quality High Purity 99% Tiotropium Bromide 136310-93-5 Fast Shipping

  • Molecular Formula:C19H22BrNO4S2
  • Molecular Weight:472.42
  • Appearance/Colour:White solid 
  • Melting Point:218-2200C 
  • PSA:115.54000 
  • LogP:-0.69150 

Tiotropium Bromide (Cas 136310-93-5) Usage

Description

Tiotropium bromide is a once-daily inhaled anticholinergic bronchodilator used for the treatment of lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). Tiotropium belongs to the family of medicines known as bronchodilators.
Mechanism of Action Blocks muscarinic receptors in airway smooth muscle. Long-acting muscarinic antagonist (LAMA).
Administration Taken by inhalation through an inhaler.
Uses Administered as a once-daily inhaled medication. Tiotropium bromide plays a crucial role in managing respiratory conditions by acting as a bronchodilator and improving airflow in individuals with lung diseases.

136310-93-5 Relevant articles

Tiotropium Bromide: A Review of its Use as Maintenance Therapy in Patients with COPD

Susan J. Keam & Gillian M. Keating

, Treatments in respiratory medicine, 2004

Tiotropium bromide (Spiriva®) is a long-acting anticholinergic bronchodilator that maintains bronchodilation for at least 24 hours, allowing once-daily administration. The active moiety is the tiotropium cation (tiotropium); tiotropium bromide 22.5µg is equivalent to 18µg of tiotropium cation.

Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype

H. Iwamoto, A. Yokoyama, N. Shiota, H. Shoda, Y. Haruta, N. Hattori, N. Kohno

, European Respiratory Journal 2008 31: 1379-1380; DOI: 10.1183/09031936.00014108

We investigated the efficacy of tiotropium bromide in 17 asthmatic patients followed in an outpatient setting at Hiroshima University Hospital (Hiroshima, Japan). Consecutive patients were selected with severe persistent asthma diagnosed and classified according to Global Initiative for Asthma guidelines...

Relevant Products

Shopping Cart

Clear Inquiry